Uw dienstverlener op het gebied van lifescience voor onderzoek, ontwikkeling en kwaliteitsborging.

GBA Key2Compliance AB is pleased to announce the appointment of Camilla Oldgren as its new Chief Executive Officer (CEO), effective June 1, 2025.

Camilla brings over 30 years of experience in the life sciences industry, with deep expertise in pharmaceuticals, medical devices, and consulting services. Her professional journey spans executive leadership in established companies as well as advisory roles helping businesses navigate growth and transformation.

The Laboratorium für Klinische Forschung GmbH (LKF), a member of the GBA Group, will now operate under the new company brand GBA Central Lab Services GmbH (GBA CLS). The rebranding initiative represents a strategic direction aimed at aligning the company’s identity with the global GBA Group and at communicating the core service with the company name. It reflects a clear commitment to enhancing international visibility, creating a consistent brand presence across all markets, and positioning GBA Central Lab Services GmbH as a unified and globally recognized provider of central laboratory services.